These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20126270)

  • 21. Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens.
    Lumbala C; Biéler S; Kayembe S; Makabuza J; Ongarello S; Ndung'u JM
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006386. PubMed ID: 29590116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interpretation of the CATT (Card Agglutination Trypanosomiasis Test) in the screening for human trypanosomiasis due to Trypanosoma brucei gambiense].
    Penchenier L; Jannin J; Moulia-Pelat JP; Elfassi de la Baume F; Fadat G; Chanfreau B; Eozenou P
    Ann Soc Belg Med Trop; 1991 Sep; 71(3):221-8. PubMed ID: 1958107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
    Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
    Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of LATEX/T.b.gambiense for mass screening of Trypanosoma brucei gambiense sleeping sickness in Central Africa.
    Penchenier L; Grébaut P; Njokou F; Eboo Eyenga V; Büscher P
    Acta Trop; 2003 Jan; 85(1):31-7. PubMed ID: 12505181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serodiagnostic tests for T.b. gambiense human African trypanosomiasis in southern Sudan.
    Elrayah IE; Rhaman MA; Karamalla LT; Khalil KM; Büscher P
    East Mediterr Health J; 2007; 13(5):1098-107. PubMed ID: 18290403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

  • 29. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Ghorashian S; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):783-91. PubMed ID: 17128358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for second-stage human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006201. PubMed ID: 23807762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary evaluation of LATEX/T. b. gambiense and alternative versions of CATT/T. b. gambiense for the serodiagnosis of human african trypanosomiasis of a population at risk in Côte d'Ivoire: considerations for mass-screening.
    Jamonneau V; Truc P; Garcia A; Magnus E; Büscher P
    Acta Trop; 2000 Sep; 76(2):175-83. PubMed ID: 10936577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis.
    Doua F; Miezan TW; Sanon Singaro JR; Boa Yapo F; Baltz T
    Am J Trop Med Hyg; 1996 Dec; 55(6):586-8. PubMed ID: 9025682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for second-stage Human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2010 Aug; (8):CD006201. PubMed ID: 20687080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon.
    Dukes P; Gibson WC; Gashumba JK; Hudson KM; Bromidge TJ; Kaukus A; Asonganyi T; Magnus E
    Acta Trop; 1992 Jun; 51(2):123-34. PubMed ID: 1354930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.
    Politi C; Carrín G; Evans D; Kuzoe FA; Cattand PD
    Health Econ; 1995; 4(4):273-87. PubMed ID: 8528430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
    Kuemmerle A; Schmid C; Bernhard S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete DN; Kisala M; Burri C; Blesson S; Valverde Mordt O
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009903. PubMed ID: 34748572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China.
    Chen N; Jin K; Xu J; Zhang J; Weng Y
    Int J Infect Dis; 2019 Feb; 79():34-36. PubMed ID: 30423460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased sensitivity of the card agglutination test CATT/Trypanosoma brucei gambiense by inhibition of complement.
    Pansaerts R; Van Meirvenne N; Magnus E; Verhelst L
    Acta Trop; 1998 Jul; 70(3):349-54. PubMed ID: 9777719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.